Dr Ahmad Tarhini explores some of the challenges of treating patients with metastatic melanoma through the use of 2 cases.
This activity is intended for oncologists, dermatologists, pathologists, nurses, and other healthcare professionals who treat patients with melanoma.
The goal of this activity is to explore the use of immunotherapy in patients with metastatic melanoma.
Approximate Time to Complete: 30 minutes
Credit Available: Dec. 17, 2017 - Dec. 17, 2018
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Select the most appropriate regimen for a patient with metastatic melanoma across the continuum of care
- Identify immune-related adverse events in patients with metastatic melanoma
- Manage immune-related adverse events in patients with metastatic melanoma